Atlas Trials

SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD

Clinical trial NCT02013375 · TERMINATED

Trial details

NCT number
NCT02013375
Sponsor
Damiano Rondelli, MD
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2014-04-10
Primary completion
2014-05-31
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.